Completed NA INTERVENTIONAL 1-arm NCT06000839

A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)

A Prospective, Open Study on the Safety and Effectiveness of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) on Healthy Subjects

Sponsor: Suisselle

Conditions Atrophic Scar Hyperpigmentation Oxidative Stress Skin Depression Skin Dryness Skin Fold Skin Laxity Skin Texture Disorder Striae Distensae

Interventions (D0) Intradermal injection - micropapula technique (D14) Intradermal injection - micropapula technique (D28) Intradermal injection - micropapula technique

Updated 3 times since 2023 Last updated: Aug 15, 2023 Started: Oct 7, 2022 Primary completion: Feb 1, 2023 Completion: Feb 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06000839, this NA trial focuses on Atrophic Scar and Hyperpigmentation and remains completed. Sponsored by Suisselle, it has been updated 3 times since 2022, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Suisselle

Data source: Suisselle

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Villeurbanne, France